Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2025-12-28 @ 2:39 PM
Study NCT ID:
NCT06902792
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-03-30
First Post:
2025-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents
Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SAHoWMU-CR2025-06-103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None